Neurocrine Biosciences Inc (NBIX) earnings · P/E 20, rev $2.86B
These earnings events as JSON? API free 100/dayNeurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
This NBIX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported NBIX revenue for 2025-12-31 was $2.86B. Net income was $478.6M. Revenue was up 21.4% from 2024-12-31 to 2025-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 20.0.
When the next NBIX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 21.4% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full NBIX research stays on the stock page; the tape stays on the quote page.
NBIX earnings FAQ
What are NBIX's latest revenue and net income?
Latest cached Neurocrine Biosciences Inc (NBIX) revenue for Dec 31, 2025 was $2.86B. Net income was $478.6M. Statements: https://lician.com/financials/nbix
What is NBIX's latest diluted EPS?
Latest cached Neurocrine Biosciences Inc (NBIX) diluted EPS for Dec 31, 2025 was $4.67.
What period does the latest NBIX earnings print cover?
The latest cached Neurocrine Biosciences Inc (NBIX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did NBIX revenue change from the prior cached period?
Cached Neurocrine Biosciences Inc (NBIX) revenue was up 21.4% from $2.36B (Dec 31, 2024) to $2.86B (Dec 31, 2025). Statements: https://lician.com/financials/nbix
What is NBIX's P/E ratio?
Neurocrine Biosciences Inc (NBIX) trailing P/E is 20.0 on the latest cached fundamentals snapshot.
Where are NBIX earnings listed?
Cached earnings facts for Neurocrine Biosciences Inc (NBIX) are listed at https://lician.com/earnings/nbix. Statements: https://lician.com/financials/nbix
Not investment advice.